Pharmaceutical companies are increasingly leveraging big data technologies to enhance innovation and operational efficiency. Recent advancements include biomarker analysis for septic shock, a cancer detection system using a 4-miRNA model, and improved bioprocess control systems. These technologies are streamlining research, personalizing treatments, and leading to more effective therapies. The impact of big data extends beyond the pharmaceutical sector, influencing various industries. GlobalData’s big data market report provides comprehensive analysis of the market. Buy the report here.
Smarter leaders trust GlobalData
This article presents a quarterly round-up of the latest trends in the pharmaceutical industry regarding big data. It provides an overview of recent developments in big data-related deals, talent acquisition, and patent filings within the pharmaceutical industry.
Diverse applications of big data in pharmaceutical industry
Pharma companies are increasingly leveraging big data technologies to enhance their innovation and operational efficiency. Recent patents highlight advancements in biomarker analysis for septic shock, enabling precise treatment strategies through gene expression profiling. Additionally, a novel cancer detection system utilizing a 4-miRNA biomarker model demonstrates exceptional accuracy, significantly improving early diagnosis capabilities. The integration of bioprocess control systems enhances the management of therapeutic production, while innovative methods for addressing autoimmune disorders utilize microbial epitope mapping to tailor treatments. These technologies not only streamline research and development processes but also facilitate personalized medicine, ultimately leading to improved patient outcomes and more effective therapies.
The industry experienced a 52% decline in the number of big data-related patent applications in Q2 2024 compared with the previous quarter. On an annual basis, the number of big data-related patent applications in the pharmaceutical industry witnessed a rise of 33% compared with Q2 2023.
Strategic deal trends in big data in pharmaceutical industry
Pharmaceutical companies are not only focusing on innovation to enhance their patent portfolios but are also making strategic investments in big data. These investments aim to secure lucrative deals with partners and position themselves at the forefront of industry advancements. Some of the recent deals underscore the importance of big data in the pharmaceutical industry.
In Q2 2024, the number of big data-related deals in the pharmaceutical industry declined by 4% compared with Q2 2023. On a quarterly basis, there was 53% drop in the number of deals in Q2 2024 compared with the previous quarter.
Impact on hiring
In terms of new job posting, in Q2 2024, the pharmaceutical industry experienced a 2% growth compared with the previous quarter. On an annual basis, job postings also declined by 8%. Notably, management occupations, with a share of 23%, emerged as the top big data-related job roles within the pharmaceutical industry in Q2 2024, with new job postings rising by 15% quarter-on-quarter. Life, physical, and social science occupations came in second with a share of 18% in Q2 2024, with new job postings rising by 8% over the previous quarter. The other prominent big data roles include computer and mathematical occupations with a 15% share in Q2 2024, and business and financial operations occupations with a 3% share of new job postings.
AstraZeneca, Novartis, Merck, AbbVie, and Sanofi are among the top companies leading in big data hiring within the pharmaceutical industry.
Countries driving adoption of big data in pharmaceutical industry
The US is the leading country in big data adoption within the pharmaceutical industry, boasting the highest number of big data-related patents, jobs, and deals. Meanwhile, Canada, Israel, China and Brazil also maintain significant positions in big data adoption within the pharmaceutical industry.
In conclusion, despite a notable decline in patent applications and deals, the continued growth in job postings highlights the sector's commitment to Big Data advancements. These innovations are set to drive significant improvements in patient outcomes and therapeutic development.
To further understand GlobalData's analysis on big data in the pharmaceutical industry, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData patent analytics tracks patent filings and grants across companies and themes. Proprietary databases on deals and job analytics are used to respectively monitor global deal activity and uncover insights from daily job postings to identify trends, company activities, and industry dynamics across different sectors globally.
